How to Use

This product is administered via subcutaneous injection using the pre-filled pen system. The injection is typically applied to areas with subcutaneous tissue, following the instructions provided in the product packaging. It is essential to follow proper handling and administration protocols to ensure accurate dosing.

Dosage

Each pen delivers approximately 1 mg per 6 clicks, allowing for controlled and adjustable dosing. Usage should be based on structured research protocols or professional guidelines, ensuring optimal peptide delivery in controlled environments.

How It Works

Retatrutide (30mg) and Cagrilintide (6mg) work synergistically to interact with metabolic and hormonal pathways, promoting the regulation of glucose and lipid metabolism. These peptides help support the balance of metabolic processes and energy regulation, essential for research into metabolic disorders and weight management. Their combined action ensures precise and controlled peptide delivery, providing researchers with consistent results.

Key Features

• Combined formulation of Retatrutide (30mg) and Cagrilintide (6mg)
• Pre-filled disposable pen for easy and accurate dosing
• Delivers 1mg per 6 clicks for controlled subcutaneous administration
• Designed for precise peptide interaction and consistent delivery
• Stable composition ensuring formulation integrity and batch consistency
• Manufactured under strict quality control standards for reliability

Safety

As with any peptide product, application responses may vary depending on individual conditions and environment. Mild, temporary reactions may occur in some cases, such as slight irritation at the injection site. Use only within controlled environments, and always adhere to professional guidance and research protocols.

Note

This product is intended for research and professional use only. It is not for general consumer use. Always consult with a qualified professional before use, and follow proper handling, administration, and storage procedures.